Use of 2-methylene-19-nor-20(S)-1a,25-dihydr oxyvitamin D3 to increase the life expectancy of human beings

Details for Australian Patent Application No. 2004280176 (hide)

International Classifications

Event Publications

13 April 2006 PCT application entered the National Phase

PCT publication WO2005/034959 Priority application(s): WO2005/034959

22 June 2006 Amendment Made

The nature of the amendment is: Amend the co-inventor name from ClagetteDame, Margaret to Clagett-Dame, Margaret

13 May 2010 Application Accepted

Published as AU-B-2004280176

23 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

4 August 2011 Corrigenda

Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2004 Delete all reference to Application No. 2004280176.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.